Compare NSPR & BDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NSPR | BDL |
|---|---|---|
| Founded | 2005 | 1959 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.1M | 62.6M |
| IPO Year | 2009 | 1995 |
| Metric | NSPR | BDL |
|---|---|---|
| Price | $1.00 | $33.31 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 221.8K | 1.2K |
| Earning Date | 05-04-2026 | 05-18-2026 |
| Dividend Yield | N/A | ★ 1.90% |
| EPS Growth | N/A | ★ 49.72 |
| EPS | N/A | ★ 1.98 |
| Revenue | $2,310,000.00 | ★ $205,248,000.00 |
| Revenue This Year | $57.98 | N/A |
| Revenue Next Year | $95.41 | N/A |
| P/E Ratio | ★ N/A | $16.82 |
| Revenue Growth | N/A | ★ 8.99 |
| 52 Week Low | $1.00 | $26.33 |
| 52 Week High | $2.93 | $35.98 |
| Indicator | NSPR | BDL |
|---|---|---|
| Relative Strength Index (RSI) | 28.19 | 58.17 |
| Support Level | N/A | $28.82 |
| Resistance Level | $1.29 | $33.69 |
| Average True Range (ATR) | 0.09 | 1.51 |
| MACD | -0.00 | 0.30 |
| Stochastic Oscillator | 9.38 | 84.18 |
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.